Company / Depreciation & Amortization
AVADEL PHARMACEUTICALS PLC Depreciation & Amortization History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.7M
FY2024
5-year range
$815.0K / $2.7M
FY2020-FY2024
Trend
+51.8%
vs FY2023
Sector context
#91 of 168
Health Care
What the data says
At $3M, AVADEL PHARMACEUTICALS PLC's depreciation & amortization ranks #78 of 168 in the Health Care sector. Depreciation & Amortization has increased for 3 consecutive years, from $815,000 in FY2021 to $3M in FY2024.
Based on SEC 10-K filings.
$3M in FY2024 with a 5-year CAGR of +1.5%.
Increased from $1M to $3M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +48.7%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Sector benchmark
#78 of 168 in Health CareTop 46% of 168This company $2.7M Sector average $212.9M
▼
-98.7% below sector average
Key checks
Key Insights
- AVADEL PHARMACEUTICALS PLC's depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of +1.5%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 51.8% year-over-year.
- Ranks #91 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.7M | +51.8% |
| FY2023 | $1.8M | +18.3% |
| FY2022 | $1.5M | +83.2% |
| FY2021 | $815.0K | -51.8% |
| FY2020 | $1.7M | -32.0% |
| FY2019 | $2.5M | -66.5% |
| FY2018 | $7.4M | +52.2% |
| FY2017 | $4.9M | -66.3% |
| FY2016 | $14.5M | +10.3% |
| FY2015 | $13.1M | -7.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026